Alcidion Group (ALC) Stock Overview
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ALC from our risk checks.
ALC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Alcidion Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.12 |
| 52 Week High | AU$0.14 |
| 52 Week Low | AU$0.051 |
| Beta | 1.7 |
| 1 Month Change | 14.63% |
| 3 Month Change | 38.24% |
| 1 Year Change | 58.78% |
| 3 Year Change | -24.19% |
| 5 Year Change | -12.96% |
| Change since IPO | 80.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALC | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -2.1% | -1.5% | 0.2% |
| 1Y | 58.8% | 117.7% | 8.9% |
Return vs Industry: ALC underperformed the Australian Healthcare Services industry which returned 117.7% over the past year.
Return vs Market: ALC exceeded the Australian Market which returned 8.9% over the past year.
Price Volatility
| ALC volatility | |
|---|---|
| ALC Average Weekly Movement | 7.7% |
| Healthcare Services Industry Average Movement | 10.7% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 18.5% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: ALC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: ALC's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 145 | Kate Quirke | www.alcidion.com |
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). Its platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; comprehensive health record for informed patient care; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions.
Alcidion Group Limited Fundamentals Summary
| ALC fundamental statistics | |
|---|---|
| Market cap | AU$161.15m |
| Earnings (TTM) | -AU$4.97m |
| Revenue (TTM) | AU$35.64m |
Is ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALC income statement (TTM) | |
|---|---|
| Revenue | AU$35.64m |
| Cost of Revenue | AU$5.09m |
| Gross Profit | AU$30.55m |
| Other Expenses | AU$35.52m |
| Earnings | -AU$4.97m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0037 |
| Gross Margin | 85.73% |
| Net Profit Margin | -13.95% |
| Debt/Equity Ratio | 0% |
How did ALC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/30 00:16 |
| End of Day Share Price | 2025/07/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alcidion Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elyse Shapiro | Bell Potter |
| Thomas Wakim | Bell Potter |
| Elyse Shapiro | Canaccord Genuity |